Advanced search
Start date
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Metabolites from Marine Sponges and Their Potential to Treat Malarial Protozoan Parasites Infection: A Systematic Review

Full text
Campos Aguiar, Anna Caroline [1] ; Parisi, Julia Risso [1] ; Granito, Renata Neves [1] ; Freitas de Sousa, Lorena Ramos [2] ; Muniz Renno, Ana Claudia [1] ; Gazarini, Marcos Leoni [1]
Total Authors: 6
[1] Fed Univ Sao Paulo UNIFESP, Dept Biosci, Rua Silva Jardim 136, BR-11015020 Santos, SP - Brazil
[2] Fed Univ Goias UFG UFCAT, Special Acad Unit Chem, BR-75704020 Catalao, Go - Brazil
Total Affiliations: 2
Document type: Review article
Source: MARINE DRUGS; v. 19, n. 3 MAR 2021.
Web of Science Citations: 0

Malaria is an infectious disease caused by protozoan parasites of the Plasmodium genus through the bite of female Anopheles mosquitoes, affecting 228 million people and causing 415 thousand deaths in 2018. Artemisinin-based combination therapies (ACTs) are the most recommended treatment for malaria; however, the emergence of multidrug resistance has unfortunately limited their effects and challenged the field. In this context, the ocean and its rich biodiversity have emerged as a very promising resource of bioactive compounds and secondary metabolites from different marine organisms. This systematic review of the literature focuses on the advances achieved in the search for new antimalarials from marine sponges, which are ancient organisms that developed defense mechanisms in a hostile environment. The principal inclusion criterion for analysis was articles with compounds with IC50 below 10 mu M or 10 mu g/mL against P. falciparum culture. The secondary metabolites identified include alkaloids, terpenoids, polyketides endoperoxides and glycosphingolipids. The structural features of active compounds selected in this review may be an interesting scaffold to inspire synthetic development of new antimalarials for selectively targeting parasite cell metabolism. (AU)

FAPESP's process: 19/19708-0 - Identification of new antimalarial compounds: a multidisciplinary strategy aimed to search for potent chemical classes against new molecular targets and different stages of life of Plasmodium spp
Grantee:Anna Caroline Campos Aguiar
Support type: Research Grants - Young Investigators Grants